Issue date: June 2009.
"The guidance was developed using the NICE single technology appraisal process."
Publisher's number: N1889.
Cetuximab for the treatment of recurrent of recurrent and/or metastatic squamous cell cancer of the head and neck by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2009. Publication and catalogue information, links to buy online and reader comments.